Victoria McMeen, MD
Allergy & Immunology · Green Bay, WINPI 1548238850
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $891 of the $1,096 with a category attached, or 81.3%. It is spread thinly across 15 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $477 and has fallen 84.4% since, to $74 in 2024.
Across 39 payments — averaging $28.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shire North American Group Inc$224
- Pfizer$184
- Sanofi$155
- Regeneron Healthcare Solutions, Inc.$118
- Genentech USA, Inc.$92
- Takeda Pharmaceuticals U.S.A., Inc.$65
- plus $257 from 9 others
What the payments were for
- Speaking & faculty fees$20018%
- Food & beverage$89181%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shire North American Group Inc | 2 | $224 |
| Pfizer | 5 | $184 |
| Sanofi | 6 | $155 |
| Regeneron Healthcare Solutions, Inc. | 5 | $118 |
| Genentech USA, Inc. | 5 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| GSK | 2 | $50 |
| AstraZeneca | 3 | $49 |
| Biocryst US Sales Co., LLC | 2 | $48 |
| Octapharma USA, Inc. | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Pharming Healthcare, Inc. | 1 | $21 |
| Kaleo, Inc. | 1 | $19 |
| CSL Behring | 1 | $16 |
| Bio Products Laboratory USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EUCRISA$130
How this compares
$1,096 in reported general payments places this provider in the 65th percentile of 55 allergy & immunology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 39 | $153,514 |
| TezspireTezepelumab-Ekko | 28 | $123,076 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 13 | $72,219 |
| Fasenra PenBenralizumab | 12 | $70,396 |
| SymbicortBudesonide/Formoterol Fumarate | 116 | $38,210 |
| Spiriva RespimatTiotropium Bromide | 60 | $33,017 |
| Advair HfaFluticasone Propion/Salmeterol | 53 | $30,268 |
| Breo ElliptaFluticasone/Vilanterol | 44 | $21,430 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 47 | $13,283 |
| DuleraMometasone/Formoterol | 16 | $10,045 |
| Arnuity ElliptaFluticasone Furoate | 20 | $5,924 |
| Qvar RedihalerBeclomethasone Dipropionate | 15 | $4,313 |
| Fluticasone Propionate HfaFluticasone Propionate | 19 | $4,041 |
| BreynaBudesonide/Formoterol Fumarate | 30 | $3,927 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 105 | $2,909 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaTezspire, Symbicort | $49 | $161,286144 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $65 | $72,21913 claims |
| GSKBreo Ellipta, Arnuity Ellipta | $50 | $27,35464 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 55 allergy & immunology providers in Wisconsin.
Other allergy & immunology in Green Bay
- Lakshmi Gopalakrishnan NairGreen Bay$3K
- Jeffrey ShawGreen Bay$2K
- Dawid PlazaGreen Bay$1K
- Ishaan JakharGreen Bay$593
- Nana Sarhoak FennyGreen Bay$432
- William BusseMadison$928K
- Jared DarveauxOnalaska$287K
- Don BuksteinFitchburg$257K
- Allan LuskinMadison$51K
- Monica VasudevSheboygan$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.